Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reury-Perng Perng

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of the Chinese Medical Association : JCMA|September 26, 2013
The epidermal growth factor receptor-tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non-small-cell lung cancerWen-Shuo Wu, Yuh-Min Chen, Chun-Ming Tsai, et al.
The Oncologist|June 10, 2015
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma PatientsYen-Han Tseng, Yen-Chiang Tseng, Yi-Hsuan Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 9, 2006
Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in TaiwanJeng-Yuan Hsu, Reury-Perng Perng, Jau-Yeong Lu, et al.
Clinical Rheumatology|February 1, 2007
Lupus erythematosus (LE) cells in ascites: initial diagnosis of systemic lupus erythematosus by cytological examination: a case reportKun-Ta Chou, Yu-Chin Lee, Chun-Wei Chen, et al.
Oncology Letters|June 17, 2014
Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lungChu-Yun Huang, Yuh-Min Chen, Chieh-Hung Wu, et al.
Critical Care (London, England)|January 12, 2011
Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational studyKuang-Yao Yang, Kuan-Ting Liu, Yu-Chun Chen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 2, 2003
Neutrophil elastase stimulates human airway epithelial cells to produce PGE2 through activation of p44/42 MAPK and upregulation of cyclooxygenase-2Diahn-Warng Perng, Yu-Chung Wu, Mei-Chuan Tsai, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxelYuh-Min Chen, Jen-Fu Shih, Chia-San Lee, et al.
Journal of the Chinese Medical Association : JCMA|March 29, 2007
Effect of age on pulmonary metastases and immunotherapy in young and middle-aged miceYuh-Min Chen, Pi-Sheng Wang, Jacqueline Ming Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR)Jin Soo Lee, Vera Hirsh, Keunchil Park, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of the Chinese Medical Association : JCMA|September 26, 2013
The epidermal growth factor receptor-tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non-small-cell lung cancerWen-Shuo Wu, Yuh-Min Chen, Chun-Ming Tsai, et al.
The Oncologist|June 10, 2015
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma PatientsYen-Han Tseng, Yen-Chiang Tseng, Yi-Hsuan Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 9, 2006
Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in TaiwanJeng-Yuan Hsu, Reury-Perng Perng, Jau-Yeong Lu, et al.
Clinical Rheumatology|February 1, 2007
Lupus erythematosus (LE) cells in ascites: initial diagnosis of systemic lupus erythematosus by cytological examination: a case reportKun-Ta Chou, Yu-Chin Lee, Chun-Wei Chen, et al.
Oncology Letters|June 17, 2014
Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lungChu-Yun Huang, Yuh-Min Chen, Chieh-Hung Wu, et al.
Critical Care (London, England)|January 12, 2011
Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational studyKuang-Yao Yang, Kuan-Ting Liu, Yu-Chun Chen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 2, 2003
Neutrophil elastase stimulates human airway epithelial cells to produce PGE2 through activation of p44/42 MAPK and upregulation of cyclooxygenase-2Diahn-Warng Perng, Yu-Chung Wu, Mei-Chuan Tsai, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxelYuh-Min Chen, Jen-Fu Shih, Chia-San Lee, et al.
Journal of the Chinese Medical Association : JCMA|March 29, 2007
Effect of age on pulmonary metastases and immunotherapy in young and middle-aged miceYuh-Min Chen, Pi-Sheng Wang, Jacqueline Ming Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR)Jin Soo Lee, Vera Hirsh, Keunchil Park, et al.
Pageof 10